While its effectiveness is still being researched, clinical therapists across the country and here at Bryan Medical say it’s mostly beneficial for treatment-resistant depression patients.

Among its growing number of users is Elon Musk, who says he takes ketamine every two weeks for depression as prescribed by a doctor. He’s far from alone: More and more Americans are turning to ...

Relief Mental Health, an award-winning outpatient provider of innovative mental health services, proudly announces the ...

According to the Montgomery-Åsberg Depression Rating Scale (MADRS ... The treatment fits nicely in the two-hour in-clinic framework established by Spravato (esketamine), but with the potential for ...

Intravenous ketamine and intranasal esketamine may reduce emergency department visits for suicide in patients with treatment resistant depression.

On Tuesday, the government agency announced Spravato nasal spray, also known as esketamine, can now be used "for the treatment of depression in adults who have tried other antidepressant ...

This decision expands the indication of esketamine, offering new hope for patients with treatment-resistant depression(1 Trusted Source FDA approves new nasal spray medication for treatment ...

27, 2025 – After years of limited options, people with hard-to-treat depression finally have a new standalone treatment. The FDA’s latest approval of the nasal spray Spravato (esketamine ...

The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult ...

Esketamine targets the glutamate neurotransmitter pathway, offering a novel mechanism for treatment-resistant depression. The treatment is available through a Risk Evaluation and Mitigation ...

Opens in a new tab or window Esketamine nasal spray (Spravato) monotherapy was helpful in improving symptoms of treatment-resistant depression, a randomized, double-blind trial found. Among 379 ...